IMMUNOLOGY FOR A NEW FUTURE
Nuravax’s mission is to develop effective and affordable preventive vaccines for Alzheimer’s and other currently untreatable diseases.
© 2022 Nuravax
01
BIOTECH COMPANY
OUR SCIENCE
We are taking on the challenge to prevent or cure diseases of the central nervous system starting with Alzheimer’s as our primary focus. We are developing a wide spectrum of products based on our universal MultiTEP vaccine platform, a novel technology solution designed to address many problems scientists face when working with CNS diseases.
02
PIPELINE
We are developing multiple vaccines for people at risk of Alzheimer’s disease, tauopathies, Parkinson’s disease, and α-synucleopathies using mostly NIA and NINDS R21s, R01s, and U01 awards. Based on our data, NIA leadership recently supported the development of a SARS-CoV-2 MultiTEP-based vaccine for the elderly.
03
PIPELINE
PUBLICATIONS
Our expert team members have published a large number of studies.
04
NEWS
05
NEWS
CONTACT
info@nuravax.com
E-mail
06